Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Axon Enterprise Inc (AXON) vs Lemonade Inc (LMND) Price & Performance

Axon Enterprise IncTrade
Lemonade IncTrade

Price performance (Past 24H)

Key statistics

Axon Enterprise Inc vs Lemonade Inc — how do they compare? Axon Enterprise Inc trades at $603.8 (market cap $51.69B), while Lemonade Inc trades at $51.7 (market cap $4.09B). The key difference: Axon Enterprise Inc is far larger — about 12.6× Lemonade Inc's market cap, and Axon Enterprise Inc is trading nearer its 52-week high, Lemonade Inc nearer its low. Which is the better fit depends on your goals.

AXONLMND
Market Cap
$51.69B$4.09B
Sector
TechnologyFinancials
52-Week High
$791.62$96.57
52-Week Low
$345.94$47.38
Enterprise Value
$52.83B$3.95B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Axon Enterprise Inc

AXON trades at $599.78, up 0.58% on the day, consolidating after a strong uptrend. The stock shows bullish technical signals with support near $616 and resistance at $649. Fundamentally, Q2 2026 revenue grew 35% year-over-year to $904 million, marking the tenth consecutive quarter of growth above 30%, with a net income margin of 6.19%. Analyst consensus is strongly bullish with an $685 price target, though valuation multiples remain elevated.

The outlook is positive given robust revenue growth and AI-driven expansion, but the high P/E of 265 presents a significant risk. Investors face a trade-off between strong operational execution and demanding valuations. Near-term catalysts include Q3 2026 earnings and continued execution on the $15.1B future contracted bookings pipeline.

Lemonade Inc

Lemonade (LMND) trades at $51.63, down 1.99% on the day, with a bearish technical signal from moving averages. Revenue growth is strong, reaching $737.9M in 2025, but the company remains unprofitable with a net income margin of -14.19%. Recent Q2 2026 earnings beat expectations, and the company targets positive adjusted EBITDA by Q4 2026, yet the stock faces selling pressure amid valuation concerns.

The outlook hinges on Lemonade's path to profitability; achieving its EBITDA target could drive upside toward the $58 consensus price target. Key risks include persistent losses, competitive pressures, and execution challenges in scaling its AI-driven insurance model. Investor sentiment is divided, reflecting the high-growth but high-burn profile.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Axon Enterprise Inc

Axon develops technology and weapons for law enforcement and military use. Its ecosystem includes TASER devices, body cameras, and Evidence.com, a cloud-based platform for digital evidence management.

Read more on AXON

About Lemonade Inc

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.

Read more on LMND